2 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
Follow Livedoid Vasculopathy: new trials by email Literature Review of Livedoid Vasculopathy trials Research Report on Livedoid Vasculopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms 0.9% nitroglycerin in TAM cream, vehicle cream - Raynaud Disease | Phase 3 | Unknown | MediQuest Therapeutics | 100 | 2009-06-01 | 2010-07-20 |
| A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon Nitroglycerin, Topical AmphiMatrix - Raynaud's Disease, Raynaud's Disease Secondary to Scleroderma | Phase 3 | Unknown | MediQuest Therapeutics | 200 | 2007-12-01 | 2010-02-05 |
Raynaud Disease (2) · Scleroderma, Diffuse (2)
Cardiovascular Diseases (2) · Connective Tissue Diseases (2) · Embolism and Thrombosis (2) · Peripheral Vascular Diseases (2) · Scleroderma, Systemic (2) · Skin Diseases (2) · Skin Diseases, Vascular (2) · Skin and Connective Tissue Diseases (2) · Thrombosis (2) · Vascular Diseases (2)
Nitroglycerin (2)
United States (2)
Jan Ohrstrom, PhD (1) · Jeff Gregory, MD (1)